{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-190800","form_type":"8-K","ticker":"IBRX","cik":"0001326110","company_name":"ImmunityBio, Inc.","filed_at":"2023-07-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.579821+00:00","generated_at":"2026-06-13T04:50:46.850230+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ImmunityBio closes $40M registered direct offering of common stock and warrants","bullets":["Issued 14,569,296 shares at $2.7455 per share with warrants for 14,569,296 shares at $3.2946.","Gross proceeds of ~$40M before fees; Jefferies as placement agent at 6% fee.","Warrants are immediately exercisable and expire 3 years from issuance.","Closing expected July 25, 2023, subject to customary conditions.","February 2023 warrants amended to match new warrants' exercise price and 3-year term."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-190800","json":"https://secwatch.observer/filing/0001193125-23-190800.json","markdown":"https://secwatch.observer/filing/0001193125-23-190800.md","text":"https://secwatch.observer/filing/0001193125-23-190800.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326110/000119312523190800/0001193125-23-190800-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326110/000119312523190800/d489429d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T04:50:46.850230+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1f9ab7a083d5edd3d87c58adbcaaeaa7d69f5b94","claim":"ImmunityBio, Inc. entered into stock purchase agreement (the “SPA”) with certain institutional investors (the “Investors”) valued at approximately $40.0 million (effective 2023-07-20).","evidence_excerpt":"On July 20, 2023, ImmunityBio, Inc. (the “Company”) entered into a stock purchase agreement (the “SPA”) with certain institutional investors (the “Investors”) for the purchase and sale of 14,569,296 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), and warrants to purchase an additional 14,569,296 shares of Common Stock at an exercise price of $3.2946 per share, for a purchase price of $2.7455 per share and accompanying warrant, generating gross proceeds from the offering of approximately $40.0 million before deducting placement agent fees and other estimated offering expenses (the “Offering”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1326110/000119312523190800/0001193125-23-190800-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain institutional investors (the “Investors”)"},{"label":"Value","value":"approximately $40.0 million"},{"label":"Effective","value":"2023-07-20"}],"fact_type":"material_agreement"},{"claim_id":"c92d02e232c604d6c084706ffaa6c298613fe039","claim":"ImmunityBio, Inc. entered into placement agency agreement (the “PAA”) with Jefferies LLC (the “Placement Agent”) (effective 2023-07-20).","evidence_excerpt":"On July 20, 2023, the Company also entered into a placement agency agreement (the “PAA”) with Jefferies LLC (the “Placement Agent”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1326110/000119312523190800/0001193125-23-190800-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Jefferies LLC (the “Placement Agent”)"},{"label":"Effective","value":"2023-07-20"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}